Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





New AI-Based Tool Rapidly and Automatically Determines Which COVID-19 Patients May Need Hospitalization

By HospiMedica International staff writers
Posted on 29 Oct 2020
A new artificial intelligence (AI)-based score considers multiple factors to predict the prognosis of individual patients with COVID-19 seen at urgent care clinics or emergency departments. More...


The tool, which was created by investigators at Massachusetts General Hospital (MGH Boston, MA, USA), can be used to rapidly and automatically determine which patients are most likely to develop complications and need to be hospitalized. Recognizing the need for a more sophisticated method to identify outpatients at greatest risk for experiencing negative outcomes, a multidisciplinary team of experts in neurology, infectious disease, critical care, radiology, pathology, emergency medicine and machine learning designed the COVID-19 Acuity Score (CoVA) based on input from information on 9,381 adult outpatients seen in MGH’s respiratory illness clinics and emergency department between March 7 and May 2, 2020.

CoVA was then tested in another 2,205 patients seen between May 3 and May 14. In this prospective validation group, 26.1%, 6.3% and 0.5% of patients experienced hospitalization, critical illness or death, respectively, within seven days. CoVA demonstrated excellent performance in predicting which patients would fall into these categories. Among 30 predictors -which included demographics like age and gender, COVID-19 testing status, vital signs, medical history and chest X-ray results (when available) - the top five were age, diastolic blood pressure, blood oxygen saturation, COVID-19 testing status and respiratory rate.

“While several other groups have developed risk scores for complications of COVID-19, ours is unique in being based on such a large patient sample, being prospectively validated, and in being specifically designed for use in the outpatient setting, rather than for patients who are already hospitalized,” said Shibani Mukerji, MD, PhD, associate director of MGH’s Neuro-Infectious Diseases Unit. “CoVA is designed so that automated scoring could be incorporated into electronic medical record systems. We hope that it will be useful in case of future COVID-19 surges, when rapid clinical assessments may be critical.”

Related Links:
Massachusetts General Hospital


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.